Cisatracurium
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152006This classification denotes a nicotinic antagonist with the molecular formula C53H72N2O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QX62KLI41N, chemically known as isoquinolinium, 2,2-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate, (1r-(1alpha,2alpha(1r(sup *),2r(sup *))))- but generally known as cisatracurium, which bears US NIH Compound Identifier 62886. European Medicines Agency schedules Cisatracurium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01319MIG. World Health Organization schedules cisatracurium in its Anatomical Therapeutic Chemical (ATC) Classification. CISATRACURIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, CISATRACURIUM remains the US FDA Preferred Term for this commodity. Cisatracurium bears US NLM identifiers UMLS ID C1096766 and NCI Concept Code C77365. SMILES: S(=O)(=O)(O)C1CCCCC1.S(=O)(=O)(O)C1CCCCC1.O(C1CC2C([N](CCC2CC1OC)(CCC(=O)OCCCCCOC(=O)CC[N]1(C(C2C(CC1)CC(OC)C(OC)C2)CC1CC(OC)C(OC)CC1)C)C)CC1CC(OC)C(OC)CC1)C.
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.